Ranitidine Recall Dents GSK India, Which Mulls Plant Sale

Blocks
Ranitidine Recall-Related Issues Hurt GSK India • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from India

More from Focus On Asia